MARCKSL1 (Myristoylated Alanine-Rich C Kinase Substrate-Like 1) activators constitute a specialized class of chemical compounds designed to modulate the activity and expression of the MARCKSL1 protein. MARCKSL1 is a cytoplasmic protein that plays a multifaceted role in cellular processes, particularly in the regulation of actin cytoskeleton dynamics and membrane trafficking. These activators are carefully engineered to interact with MARCKSL1, influencing its functions, and potentially altering its impact on cellular processes. Mechanistically, MARCKSL1 activators can engage with specific domains of the protein, affecting its phosphorylation status, intracellular localization, and interactions with other proteins or lipids.
Research on MARCKSL1 activators is pivotal for deepening our understanding of the complex regulatory networks that govern cytoskeletal dynamics and membrane trafficking within cells. Scientists in this field focus on uncovering the precise molecular mechanisms through which these compounds impact MARCKSL1's functions and their downstream effects on cell motility, membrane remodeling, and vesicular transport. MARCKSL1 is known to interact with key signaling pathways and cellular structures, making it a critical player in processes such as cell migration, neurite outgrowth, and exocytosis. Therefore, elucidating the role of MARCKSL1 activators contributes to our broader comprehension of fundamental cellular processes, shedding light on the intricate molecular choreography underlying cellular structure and function. These activators serve as valuable tools for researchers seeking to investigate the molecular basis of cytoskeletal dynamics and membrane trafficking, ultimately advancing our knowledge of cellular biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PKC activator; might influence MARCKSL1 expression through protein kinase C (PKC) pathways. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Pan-PKC inhibitor; could potentially influence MARCKSL1 expression. | ||||||
Rottlerin | 82-08-6 | sc-3550 sc-3550B sc-3550A sc-3550C sc-3550D sc-3550E | 10 mg 25 mg 50 mg 1 g 5 g 20 g | $84.00 $166.00 $302.00 $2091.00 $5212.00 $16657.00 | 51 | |
Reported to inhibit PKC; might affect MARCKSL1 expression, though its specificity is debated. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor; could influence MARCKSL1 through its effects on the PI3K/Akt pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor; could potentially modulate MARCKSL1 expression through MAPK pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor; might influence MARCKSL1 expression through the JNK pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor; could potentially influence MARCKSL1 expression through mTOR signaling pathways. | ||||||
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 | 612847-09-3 | sc-202048 sc-202048A | 1 mg 5 mg | $208.00 $270.00 | 29 | |
Akt inhibitor; might modulate MARCKSL1 expression by influencing Akt signaling. | ||||||